Chapter 7
Autism Case Study
Answers
- A – Risk for self-injury related to head banging and scratching. Self-injurious behaviors are an immediate safety concern and should be prioritized.
- D – Asking Diego’s mother to interpret his nonverbal cues and provide a pain rating. Diego’s mother is the most familiar with his nonverbal cues and can accurately assess his pain.
- B – Diego will demonstrate one alternative coping mechanism when feeling agitated. This is a realistic, measurable goal that aligns with Diego’s developmental stage and abilities.
- B – Diego’s agitation decreased from highly agitated to mildly agitated following the implementation of sensory strategies, including dimming lights and providing noise-canceling headphones. The documentation is specific and reflects measurable changes in Diego’s behavior.
- B – Sensory sensitivities related to food textures can be common in children and may be linked to developmental or sensory processing issues. Forcing a child to eat certain foods or implementing overly strict routines can increase mealtime stress and worsen eating behaviors. A registered dietician can assess Diego’s specific needs and preferences and help develop a plan that meets his nutritional requirements while respecting his sensory challenges.
- C – Place soft padding around Diego to minimize injury and allow him to calm down independently. Ensuring safety while allowing self-regulation helps manage frustration without escalating agitation.
Mental Health Medication Match Up
Answer Key
| Medication Class and Examples | Anxiety | Depression | Bipolar | Schizophrenia | SUD | Eating Disorder | ADHD |
|---|---|---|---|---|---|---|---|
| SSRI (fluoxetine, sertraline, citalopram) | X | X | X – Bulimia | ||||
| SNRI (venlafaxine, duloxetine, atomoxetine) | X | X | X | ||||
| Mood Stabilizer (lithium) | X | ||||||
| Benzodiazepines (clonazepam, alprazolam, lorazepam) | X | Withdrawal | |||||
| Anticonvulsant (gabapentin, valproic acid) | X | X | |||||
| Anxiolytic (buspirone) | X | ||||||
| First-Generation Antipsychotic (haloperidol, chlorpromazine) | X | ||||||
| NDRI (bupropion) | X | ||||||
| Beta-Blocker (propranolol) | X | ||||||
| Stimulants (methylphenidate) | X | ||||||
| Second-Generation Antipsychotic (risperidone) | X | X | |||||
| MAOI (isocarboxazid) | X | X |
Please find answers to the Learning Activity interactive elements within the element.